FR2766088B1 - Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire - Google Patents

Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire

Info

Publication number
FR2766088B1
FR2766088B1 FR9709089A FR9709089A FR2766088B1 FR 2766088 B1 FR2766088 B1 FR 2766088B1 FR 9709089 A FR9709089 A FR 9709089A FR 9709089 A FR9709089 A FR 9709089A FR 2766088 B1 FR2766088 B1 FR 2766088B1
Authority
FR
France
Prior art keywords
extrusion
manufacture
devices
controlled release
pharmaceutical agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9709089A
Other languages
English (en)
Other versions
FR2766088A1 (fr
Inventor
Louis Michel Jacques Aguadisch
Patrick Robert Peignot
Frederic Jean Claude Goutte
Alain Etienne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Belgium SPRL
Dow Corning France SAS
Original Assignee
Dow Corning SA
Dow Corning France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning SA, Dow Corning France SAS filed Critical Dow Corning SA
Priority to FR9709089A priority Critical patent/FR2766088B1/fr
Priority to US09/113,636 priority patent/US6120791A/en
Priority to DE69823275T priority patent/DE69823275T2/de
Priority to EP98305618A priority patent/EP0891769B1/fr
Priority to AU76184/98A priority patent/AU731760B2/en
Priority to JP20384698A priority patent/JP4442939B2/ja
Publication of FR2766088A1 publication Critical patent/FR2766088A1/fr
Application granted granted Critical
Publication of FR2766088B1 publication Critical patent/FR2766088B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
FR9709089A 1997-07-17 1997-07-17 Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire Expired - Fee Related FR2766088B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9709089A FR2766088B1 (fr) 1997-07-17 1997-07-17 Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
US09/113,636 US6120791A (en) 1997-07-17 1998-07-10 Methods for making controlled release devices for pharmaceuticals
DE69823275T DE69823275T2 (de) 1997-07-17 1998-07-15 Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Arzneimitteln
EP98305618A EP0891769B1 (fr) 1997-07-17 1998-07-15 Procédé de fabrication de dispositifs pour la libération controlée de médicaments
AU76184/98A AU731760B2 (en) 1997-07-17 1998-07-16 Methods for making controlled release devices for pharmaceuticals
JP20384698A JP4442939B2 (ja) 1997-07-17 1998-07-17 薬剤放出制御型デバイスの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709089A FR2766088B1 (fr) 1997-07-17 1997-07-17 Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire

Publications (2)

Publication Number Publication Date
FR2766088A1 FR2766088A1 (fr) 1999-01-22
FR2766088B1 true FR2766088B1 (fr) 2001-01-05

Family

ID=9509324

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9709089A Expired - Fee Related FR2766088B1 (fr) 1997-07-17 1997-07-17 Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire

Country Status (6)

Country Link
US (1) US6120791A (fr)
EP (1) EP0891769B1 (fr)
JP (1) JP4442939B2 (fr)
AU (1) AU731760B2 (fr)
DE (1) DE69823275T2 (fr)
FR (1) FR2766088B1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
FI111057B (fi) 2000-05-29 2003-05-30 Conenor Oy Ekstruusiomenetelmä ja ekstruusiolaite
DE60110192T2 (de) * 2000-12-07 2006-03-09 Warner-Lambert Company Llc Verfahren und System zur gleichmäßigen Arzneistoffabgabe
FR2829141B1 (fr) * 2001-09-03 2006-12-15 Nexans Procede de fabrication d'un corps cylindrique et cable comportant un corps obtenu par ce procede
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
BR0309844A (pt) * 2002-05-07 2005-02-15 Control Delivery Sys Inc Processos para formação de um dispositivo para a distribuição de droga
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946106A (en) * 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
FR2745180B1 (fr) * 1996-02-23 1998-05-07 Dow Corning Sa Procede de fabrication de dispositifs a liberation controlee
FR2753086B1 (fr) * 1996-09-12 1999-02-26 Hospal R & D Int Dispositif et procede de fabrication d'une capsule tubulaire segmentee contenant un milieu biologiquement actif

Also Published As

Publication number Publication date
AU7618498A (en) 1999-01-28
DE69823275D1 (de) 2004-05-27
EP0891769B1 (fr) 2004-04-21
DE69823275T2 (de) 2005-04-21
FR2766088A1 (fr) 1999-01-22
EP0891769A1 (fr) 1999-01-20
AU731760B2 (en) 2001-04-05
JPH1171263A (ja) 1999-03-16
JP4442939B2 (ja) 2010-03-31
US6120791A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
DE69530325D1 (de) Aerosol-arzneiformulierungen
MA26576A1 (fr) Formulation pharmaceutique orale a liberation prolongee
FR2776520B1 (fr) Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
NO995753D0 (no) Gastroretarderende mikrosfaerer med styrt frigivelse for bedret administrasjon av medikament
FR11C0007I2 (fr) Composition pharmaceutique stabilisee a l'aide d'un agent de base
DE69600221D1 (de) Naphthalinderivate, ihre Herstellungsverfahren und Zwischenprodukte dafür, und diese enthaltende pharmazeutische Zusammensetzungen
BR9607905A (pt) Cápsulas sem costura
MA26577A1 (fr) Formulation pharmaceutique orale a liberation pulsee
BR9609307A (pt) Preparação farmacéutica estável novo para a produção de aerossóis livres de propelentes
EP0567653A4 (en) Drug for hepatic diseases
BR9607095A (pt) Composto composição farmacêutica e processos para fabricar e para administrar um composto
FR2766088B1 (fr) Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire
ITMI922885A1 (it) Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
FR2745500B1 (fr) Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
EE05317B1 (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
NO20000811D0 (no) Fremgangsmåte for valg av medicament
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
FI950575A0 (fi) 3- ja 5-substituoidut 1,2,3,4-oksatriatsoli-5-imiiniyhdisteet, niiden valmistusmenetelmä, mainittuja yhdisteitä sisältävä farmaseuttinen valmiste ja mainittujen yhdisteiden käyttö lääkkeiden valmistukseen
FR2760190B1 (fr) Composition pharmaceutique pour la liberation programmee de dexfenfluramine
ITMI941408A0 (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei
FI950008A0 (fi) Farmaseuttinen koostumus kontrolloitua vapautumistFarmaseuttinen koostumus kontrolloitua vapautumista varten a varten
SI1043976T1 (sl) Oralna farmacevtska dozirna oblika s podaljsanim sproscanjem
GB9101563D0 (en) New pharmacologically active catechol derivatives

Legal Events

Date Code Title Description
ST Notification of lapse